THERAPEUTIC AGENTS

Brand Owner (click to sort) Address Description
AXOSINE Boston Life Sciences, Inc. 20 Newbury Street Boston MA 02116 For therapeutic agents, namely for treatment of stroke and CNS inflammation, reducing penumbral stroke damage and for shrinking neural tissue, including inosine containing compositions for infusion including infusion ito cerebral spinal fluid;
CANNA COMPANION Canna Companion 928 Merea Lane Sultan WA 98294 Therapeutic agents, namely, dosage form health supplements for animals for the support of mobility, GI tract, immunity, neurological, demeanor, comfort issues, and the endocannabinoid system containing federally lawful naturally-occurring cannabinoids found exclusively in federally lawful sources of the Cannabis sativa L. plant, not containing added CBD; Topical preparations, namely, creams, gels, and sprays for animals for the support of mobility, demeanor, and comfort issues containing federally lawful naturally-occurring cannabinoids found exclusively in federally lawful sources of the Cannabis sativa L. plant;CANNA;
NEXELL Nexell Therapeutics, Inc. 9 Parker Irvine CA 926181605 Therapeutic agents, namely, separated, selected, and modified cells; chemical products and chemical reagents, for use in medical science; biological products and biological by-products, namely, biological products and by-products for treating and diagnosing diseases in humans;
NEXELL Nexell Therapeutics, Inc. 9 Parker Irvine CA 926181605 Therapeutic agents, namely, separated, selected, and modified cells; chemical products and chemical reagents, for use in medical science; biological products and biological by-products, namely, biological products and by-products for treating and diagnosing diseases in humans;
 

Where the owner name is not linked, that owner no longer owns the brand

   
Technical Examples
  1. The present invention relates to a system and method for the delivery of therapeutic agents, such as therapeutic drugs or genetic material, into the muscle or tissue that minimizes the loss of therapeutic agents due to contraction of the muscle. In one embodiment, an implant for delivering therapeutic agents into a muscle is provided, wherein the implant has at least one rod for insertion and delivery of therapeutic agents into the muscle and a patch that can be attached to the exterior surface of the muscle for preventing or minimizing therapeutic agent being expelled due to the contraction of the muscle, such as the beating of a heart muscle.